BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 30322860)

  • 21. Nuclear Lamin A/C Expression Is a Key Determinant of Paclitaxel Sensitivity.
    Smith ER; Leal J; Amaya C; Li B; Xu XX
    Mol Cell Biol; 2021 Jun; 41(7):e0064820. PubMed ID: 33972393
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reorganization of paclitaxel-stabilized microtubule arrays at mitotic entry: roles of depolymerizing kinesins and severing proteins.
    Leung JC; Cassimeris L
    Cancer Biol Ther; 2019; 20(10):1337-1347. PubMed ID: 31345098
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The co-chaperone UNC45A is essential for the expression of mitotic kinase NEK7 and tumorigenesis.
    Eisa NH; Jilani Y; Kainth K; Redd P; Lu S; Bougrine O; Abdul Sater H; Patwardhan CA; Shull A; Shi H; Liu K; Elsherbiny NM; Eissa LA; El-Shishtawy MM; Horuzsko A; Bollag R; Maihle N; Roig J; Korkaya H; Cowell JK; Chadli A
    J Biol Chem; 2019 Apr; 294(14):5246-5260. PubMed ID: 30737284
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The UNC-45 myosin chaperone: from worms to flies to vertebrates.
    Lee CF; Melkani GC; Bernstein SI
    Int Rev Cell Mol Biol; 2014; 313():103-44. PubMed ID: 25376491
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Beyond Chaperoning: UCS Proteins Emerge as Regulators of Myosin-Mediated Cellular Processes.
    Odunuga OO; Oberhauser AF
    Subcell Biochem; 2023; 101():189-211. PubMed ID: 36520308
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bisphosphorylated PEA-15 sensitizes ovarian cancer cells to paclitaxel by impairing the microtubule-destabilizing effect of SCLIP.
    Xie X; Bartholomeusz C; Ahmed AA; Kazansky A; Diao L; Baggerly KA; Hortobagyi GN; Ueno NT
    Mol Cancer Ther; 2013 Jun; 12(6):1099-111. PubMed ID: 23543364
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Survivin deregulation in beta-tubulin mutant ovarian cancer cells underlies their compromised mitotic response to taxol.
    Zhou J; O'brate A; Zelnak A; Giannakakou P
    Cancer Res; 2004 Dec; 64(23):8708-14. PubMed ID: 15574781
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential turnover of myosin chaperone UNC-45A isoforms increases in metastatic human breast cancer.
    Guo W; Chen D; Fan Z; Epstein HF
    J Mol Biol; 2011 Sep; 412(3):365-78. PubMed ID: 21802425
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Weakened spindle checkpoint with reduced BubR1 expression in paclitaxel-resistant ovarian carcinoma cell line SKOV3-TR30.
    Fu Y; Ye D; Chen H; Lu W; Ye F; Xie X
    Gynecol Oncol; 2007 Apr; 105(1):66-73. PubMed ID: 17234259
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeting the actin/tropomyosin cytoskeleton in epithelial ovarian cancer reveals multiple mechanisms of synergy with anti-microtubule agents.
    Xu X; Wang Y; Bryce NS; Tang K; Meagher NS; Kang EY; Kelemen LE; Köbel M; Ramus SJ; Friedlander M; Ford CE; Hardeman EC; Gunning PW
    Br J Cancer; 2021 Jul; 125(2):265-276. PubMed ID: 33981016
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Exposure to low intensity ultrasound removes paclitaxel cytotoxicity in breast and ovarian cancer cells.
    Amaya C; Luo S; Baigorri J; Baucells R; Smith ER; Xu XX
    BMC Cancer; 2021 Sep; 21(1):981. PubMed ID: 34470602
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MTR120/KIAA1383, a novel microtubule-associated protein, promotes microtubule stability and ensures cytokinesis.
    Fong KW; Leung JW; Li Y; Wang W; Feng L; Ma W; Liu D; Songyang Z; Chen J
    J Cell Sci; 2013 Feb; 126(Pt 3):825-37. PubMed ID: 23264731
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alterations in ovarian cancer cell adhesion drive taxol resistance by increasing microtubule dynamics in a FAK-dependent manner.
    McGrail DJ; Khambhati NN; Qi MX; Patel KS; Ravikumar N; Brandenburg CP; Dawson MR
    Sci Rep; 2015 Apr; 5():9529. PubMed ID: 25886093
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The microtubule-associated protein EML3 regulates mitotic spindle assembly by recruiting the Augmin complex to spindle microtubules.
    Luo J; Yang B; Xin G; Sun M; Zhang B; Guo X; Jiang Q; Zhang C
    J Biol Chem; 2019 Apr; 294(14):5643-5656. PubMed ID: 30723163
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Targeted inhibition of phosphatidyl inositol-3-kinase p110β, but not p110α, enhances apoptosis and sensitivity to paclitaxel in chemoresistant ovarian cancers.
    Jeong JY; Kim KS; Moon JS; Song JA; Choi SH; Kim KI; Kim TH; An HJ
    Apoptosis; 2013 Apr; 18(4):509-20. PubMed ID: 23371322
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HE4 promotes collateral resistance to cisplatin and paclitaxel in ovarian cancer cells.
    Ribeiro JR; Schorl C; Yano N; Romano N; Kim KK; Singh RK; Moore RG
    J Ovarian Res; 2016 May; 9(1):28. PubMed ID: 27184254
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Low MAD2 expression levels associate with reduced progression-free survival in patients with high-grade serous epithelial ovarian cancer.
    Furlong F; Fitzpatrick P; O'Toole S; Phelan S; McGrogan B; Maguire A; O'Grady A; Gallagher M; Prencipe M; McGoldrick A; McGettigan P; Brennan D; Sheils O; Martin C; W Kay E; O'Leary J; McCann A
    J Pathol; 2012 Apr; 226(5):746-55. PubMed ID: 22069160
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inactivation of the mitotic checkpoint as a determinant of the efficacy of microtubule-targeted drugs in killing human cancer cells.
    Lee EA; Keutmann MK; Dowling ML; Harris E; Chan G; Kao GD
    Mol Cancer Ther; 2004 Jun; 3(6):661-9. PubMed ID: 15210851
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tuning microtubule dynamics to enhance cancer therapy by modulating FER-mediated CRMP2 phosphorylation.
    Zheng Y; Sethi R; Mangala LS; Taylor C; Goldsmith J; Wang M; Masuda K; Carrami EM; Mannion D; Miranda F; Herrero-Gonzalez S; Hellner K; Chen F; Alsaadi A; Albukhari A; Fotso DC; Yau C; Jiang D; Pradeep S; Rodriguez-Aguayo C; Lopez-Berestein G; Knapp S; Gray NS; Campo L; Myers KA; Dhar S; Ferguson D; Bast RC; Sood AK; von Delft F; Ahmed AA
    Nat Commun; 2018 Feb; 9(1):476. PubMed ID: 29396402
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Octreotide-Paclitaxel Conjugate Reverses Paclitaxel Resistance by p38 Mitogen-Activated Protein Kinase (MAPK) Signaling Pathway in A2780/Taxol Human Ovarian Cancer Cells.
    Fan LL; Chen X; Zhang XY; Li ZM; Fan XM; Shen Y
    Med Sci Monit; 2020 Aug; 26():e922612. PubMed ID: 32829374
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.